(1R)-1,5-Dihydroxy Empagliflozin D4
| Product Name | (1R)-1,5-Dihydroxy Empagliflozin D4 |
|---|---|
| Alternate Names | Empagliflozin Stable Isotopes, Stable Isotopes of Empagliflozin |
| CAT No. | CS-O-12059 |
| CAS No. | 1620758-34-0(Unlabeled) |
| Category | Stable Isotopes |
| Stock | Enquire |
| Mol. Wt. | Not Available |
| Mol. For. | Not Available |
| Hazardous | This is not a Hazardous Compound |
| COA | View Sample COA |
| MSDS | View Sample MSDS |
| Parent API | Empagliflozin |
| Therapeutic | Anti-Diabetic |
| Smileys | ClC1=CC=C([C@@H](O)[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO)C=C1CC2=C([2H])C([2H])=C(O[C@H]3CCOC3)C([2H])=C2[2H] |
| Canonical Smiles | C1COCC1OC2=CC=C(C=C2)CC3=C(C=CC(=C3)C(C(C(C(C(CO)O)O)O)O)O)Cl |
| InchIKey | RKDDAJYLEWTGMU-PNZPLEPNSA-N |
| Inchl | InChI=1S/C23H29ClO8/c24-18-6-3-14(20(27)22(29)23(30)21(28)19(26)11-25)10-15(18)9-13-1-4-16(5-2-13)32-17-7-8-31-12-17/h1-6,10,17,19-23,25-30H,7-9,11-12H2/t17-,19+,20+,21+,22-,23-/m0/s1 |
| IUPAC | (1R,2S,3R,4R,5R)-1-[4-chloro-3-[[4-[(3S)-oxolan-3-yl]oxyphenyl]methyl]phenyl]hexane-1,2,3,4,5,6-hexol |
| Controlled | No |
| Shipping | Free for purchase above 1000$ |
| Delivery | In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
| Return | Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
| Ordering | Place your order online or by email sales@clearsynth.com |
(1R)-1,5-Dihydroxy Empagliflozin D4 is a medicinal compound that is used to treat type 2 diabetes. It works by inhibiting the sodium-glucose co-transporter 2 (SGLT2), which is responsible for the reabsorption of glucose in the kidneys. By inhibiting SGLT2, this compound reduces the amount of glucose reabsorbed by the kidneys, leading to increased glucose excretion in the urine and a lowering of blood glucose levels.
Chemically, (1R)-1,5-Dihydroxy Empagliflozin D4 is a deuterated analog of Empagliflozin, which means it contains four atoms of deuterium in its molecular structure. The molecular formula of this compound is C23H25D4ClO11, and its molecular weight is 544.98 g/mol. It is a white to off-white crystalline powder that is soluble in water and organic solvents.
(1R)-1,5-Dihydroxy Empagliflozin D4 is administered orally in the form of tablets or capsules. The recommended dose for adult patients is usually 10 mg once daily, taken in the morning with or without food. However, the dosage may vary depending on the patient's individual condition and response to treatment. It is important to follow the prescribed dosage and to consult a healthcare professional before making any changes to the treatment regimen.
In summary, (1R)-1,5-Dihydroxy Empagliflozin D4 is a useful medication for managing type 2 diabetes. Its mechanism of action is by inhibiting SGLT2, and it is administered orally. It is important to follow the prescribed dosage and to consult a healthcare professional before making any changes to the treatment regimen.
Get an Instant Quote
Related Compounds
Empagliflozin 13C6 | Empagliflozin D4 | Empagliflozin D8 | Empagliflozin 13C6 | Empagliflozin D6 |